Simultaneous determination of cholecystokinin-like immunoreactivity and dopamine release after treatment with veratrine, NMDA, scopolamine and SCH23390 in rat medial frontal cortex: A brain microdialysis study

Brain Research

Volumn 735, Issue 1, 1996, Pages 30-35

  Liu, Jian Kai ^a   Kato, Takeshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cholecystokinin; Dopamine; Frontal cortex; Microdialysis; N Methyl D aspartate; Release; Scopolamine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CEVADINE; CHOLECYSTOKININ; DOPAMINE; DOPAMINE 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

EID: 0030607151     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00577-X     Document Type: Article

References (40)

1. [1] Appleyard, M.E., Acetylcholinesterase induces long-term potentiation in CA1 pyramidal cells by a mechanism dependent on metabotropic glutamate receptors, Neurosci. Lett., 190 (1995) 25-28.
2. [2] Baile, C.A., Della-Fera, M.A., Brown, D.R. and Colman, B.D., CCK receptor blocker CR 1409 increase feeding and reverses CCK-8 mediated satiety after lateral cerebral ventricular (LCV) injection in sheep, Soc. Neurosci. Abstr., 15 (1989) 1279.
3. [3] Balschun, D. and Reymann, K.G., Cholecystokinin (CCK-8S) prolongs 'unsaturated' θ-pulse induced long-term potentiation in rat hippocampal CA1 in vitro, Neuropeptides, 26 (1994) 421-427.
4. [4] Bandopadhyay, R. and De Belleroche, J., Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions, Neuropeptides, 18 (1991) 159-163.
5. [5] Brodin, E., Rosén, A., Schött, E. and Brodin, K., Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal gray and limbic regions, Neuropeptides, 26 (1994) 253-260.
6. [6] Broersen, L.M., Heinsbroek, R.P.W., De Bruin, J.P.C., Uylings, H.B.M. and Olivier, B., The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms, Brain Res., 674 (1995) 221-229.
7. [7] Bucher, S.P., Varro, A., Kelly, J.S. and Dockray, G.J., In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion, Brain Res., 505 (1989) 119-122.
8. [8] Conzelmann, U., Holland, A. and Meyer, D.K., Effects of selective dopamine D2-receptor antagonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum, Eur. J. Pharmacol., 101 (1984) 119-125.
9. [9] Fukamauchi, F., Yoshikawa, T. and Shibuya, H., Pre-synaptic dopaminergic control mechanisms for CCK-8 like immunoreactivity in the rat medial frontal cortex, Neuropeptides, 23 (1992) 55-59.
10. [10] Hasselmo, M.E. and Bower, J.M., Acetylcholine and memory, Trends Neurosci., 16 (1993) 218-222.
11. [11] Hommer, D.W., Stoner, G., Crawley, J.N., Paul, S.M. and Skirboll, L.R., Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype, J. Neurosci., 6 (1986) 3039-3043.
12. [12] Hutchison, J., Strupish, J. and Nahorski, S., Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists, Brain Res., 370 (1986) 310-314.
13. [13] Itoh, S., Takashima, A. and Katsuura, G., Preventive effect of cholecystokinin octapeptide on scopolamine-induced memory impairment in the rat, Drug Dev. Res., 12 (1988) 63-70.
14. [14] Itoh, S., Takashima, A., Igano, K. and Inouye, K., Memory effect of caerulein and its analogs in active and passive avoidance responses in the rats, Peptides, 10 (1989) 843-848.
15. [15] Katsuura, G. and Itoh, S., Prevention of experimental amnesia by peripherally administered cholecystokinin octapeptide in the rat, Drug Dev. Res., 7 (1986) 269-276.
16. [16] Kimura, F., Nishigori, A., Shirokawa, T. and Tsumoto, T., Long-term potentiation and N-methyl-D-aspartate receptor in the visual cortex of young rats, J. Physiol., 414 (1989) 125-144.
17. [17] Larsson, L.I. and Rehfeld, J.F., Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system, Brain Res., 165 (1979) 210-218.
18. [18] Liu, J.K. and Kato, T., Effects of acetylcholine agonist and antagonist on in vivo release of cholecystokinin in rat cerebral cortex with a microdialysis method, IBRO Abstr., (1995) 165.
19. [19] Lydiard, R.B., Neuropeptides and anxiety: Focus on cholecystokinin. Clin. Chem., 40 (1994) 315-318.
20. [20] MacDonald, J.F., Mody, I. and Salter, M.W., Regulation of N-methyl-D-aspartate receptors revealed by intracellular dialysis of murine neurons in culture, J. Physiol., 414 (1989) 17-34.
21. [21] Maidment, N.T., Siddall, B.J., Rudolph, V.R., Erdelyi, E. and Evans, C.J., Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay, Neuroscience, 45 (1991) 81-93.
22. [22] Maurice, T., Hiramatsu, M., Kameyama, T., Hasegawa, T. and Nabeshima, T., Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice, J. Pharmacol. Exp. Ther., 269 (1994) 665-673.
23. [23] Meana, J.J., Herrera-Marschitz, M., Brodin, E., Hökfelt, T. and Ungerstedt, U., Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis, Amino Acids, 1 (1991) 365-373.
24. [24] Meyer, D.K. and Krauss, J., Dopamine modulates cholecystokinin release in neostriatum, Nature, 301 (1983) 338-340.
25. 1-receptor stimulation reduces neostriatal cholecystokinin release, Eur. J. Pharmacol., 104 (1984) 387-388.
26. [26] Parnavelus, J.G., Morphology and distribution of peptide containing neurons in the cerebral cortex. In P.C. Emson, M.N. Rossor and M. Tohyama (Eds.), Progress in Brain Research, Vol. 66, 1986, pp. 119-134.
27. [27] Paudice, P. and Raiteri, M., Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens, Br. J. Pharmacol., 103 (1991) 1790-1794.
28. [28] Pavlasevic, S., Bednar, I., Qureshi, G.A. and Södersten, P., Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety, NeuroReport, 5 (1993) 225-228.
29. [29] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
30. [30] Rich-Bennett, E., Dahl, D. and Lecompte III, B.B., Modulation of paired-pulse activation in the hippocampal dentate gyrus by cholecystokinin, baclofen and bicuculline, Neuropeptides, 24 (1993) 263-270.
31. [31] Sharp, T., Zetterström, T., Christmanson, L. and Ungerstedt, U., p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo, Neurosci. Lett., 72 (1986) 320-324.
32. [32] Suzuki, T., Moroji, T., Hori, T., Baba, A., Kawai, N. and Koizumi, J., Autoradiographic localization of CCK-8 binding sites in the rat brain: effects of chronic methamphetamine administration on these sites, Biol. Psychiatry, 34 (1993) 781-790.
33. [33] Takashima, A., Maeda, Y. and Itoh, S., Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat, Peptides, 14 (1993) 1067-1071.
34. [34] Takeda, K., Uchiumi, F., Takita, M. and Kato, T., A rapid enzyme immunoassay for cholecystokinin octapeptide sulfate, Neurochem. Int., 15 (1989) 55-60.
35. [35] Takita, M., Tsuruta, T., Oh-hashi, Y. and Kato, T., In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditions, Neurosci. Lett. 100 (1989) 249-253.
36. [36] Vallebuona, F., Paudice, P. and Raiteri, M., Release of cholecystokinin-like immunoreactivity in the frontal cortex of conscious rats as assessed by transcerebral microdialysis: effects of different depolarizing stimuli, J. Neurochem., 61 (1993) 490-495.
37. A, NMDA and muscarinic receptors in induction of long-term potentiation in the medial and lateral amygdala in vitro, Neurosci. Res., 21 (1995) 317-322.
38. [38] Xu, M. and Kalo, T., Brain dialysis: changes in the activities of dopamine neurons in rat striatum by perfusion of acetylcholine agonists under freely moving conditions, Neurochem. Int., 12 (1988) 539-545.
39. [39] Yaksh, T., Furui, T., Kanawati, I.S. and Go, V.L.W., Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems, Brain Res., 406 (1987) 207-214.
40. [40] Záborszky, L., Alheid, G.F., Beinfeld, M.C., Eiden, L.E., Heimer, L. and Palkovits, M., Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study, Neuroscience, 14 (1985) 427-453.